Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) - Concepedia

Concepedia

Publication | Open Access

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)

DOI Full Paper Access

86

Citations

26

References

2017

Year

Naoya Yamazaki, Tatsuya Takenouchi, Manabu Fujimoto, Hironobu Ihn, Hiroshi Uchi, Takashi Inozume, Yoshio Kiyohara, Hisashi Uhara, Kazuhiko Nakagawa, Hiroshi Furukawa,

Cancer Chemotherapy and Pharmacology

Phase 1BAnti-pd-1 Monoclonal AntibodyMedicineMelanomaImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyAdvanced Melanoma

References

	Year	Citations

Page 1

Page 1